What is Biodesix Inc (BDSX) stock price today?

Biodesix Inc (BDSX) currently trades at $15.32 per share. The stock has a market capitalization of $113.91M and a P/E ratio of —x.

Is BDSX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Biodesix Inc has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Biodesix Inc's revenue and earnings?

Biodesix Inc has trailing twelve-month (TTM) revenue of $88.50M with profit margins of -39.90%. Earnings per share (EPS) is $-4.75.

Is BDSX stock overvalued or undervalued?

Based on our DCF model, Biodesix Inc's intrinsic value is $19.42, representing a margin of safety of 46.70%. The stock currently trades at a P/E of —x.

BDSX

Biodesix Inc

NASDAQ: BDSX · HEALTHCARE · DIAGNOSTICS & RESEARCH

$15.32

-0.97% today

Updated 2026-05-08

Market cap

$113.91M

P/E ratio

—

P/S ratio

1.29x

EPS (TTM)

$-4.75

Dividend yield

—

52W range

$3 – $20

Volume

0.1M

Market cap

$113.91M

P/E ratio

—

P/S ratio

1.29x

EPS (TTM)

$-4.75

Dividend yield

—

52W range

$3 – $20

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

8.0

Growth

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →197 stocks currently score above 75

Price targets

Analyst target

$30.00

+95.82%

12-Month target

—

Intrinsic (DCF)

$19.42

Margin of safety

+46.70%

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Revenue growth 40.80% QoQ

+ 46.70% below intrinsic value

Risks

- Thin margins at -39.90%

- Negative free cash flow $-10.31M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$38.21M	$49.09M	$71.32M	$88.50M	$88.50M
Net income	$-65.45M	$-52.15M	$-42.93M	$-35.27M	$-7.79M
EPS	—	—	—	—	$-4.75
Free cash flow	$-48.51M	$-45.93M	$-51.88M	$-23.67M	$-10.31M
Profit margin	-171.27%	-106.23%	-60.19%	-39.85%	-39.90%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BDSX	$113.91M	30	8.0	2.0	6.7	5.0	+46.70%	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-38.45%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-20.52%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+42.20%	Buy
AZN	$286.68B	62	6.0	8.5	5.3	5.0	+6.69%	Buy

Smart narrative

Biodesix Inc trades at $15.32. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $88.50M. with profit margins at -39.90%. Our DCF model estimates intrinsic value at $19.42.

Frequently asked questions

What is Biodesix Inc's stock price?

Biodesix Inc (BDSX) trades at $15.32.

Is Biodesix Inc overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell). DCF value $19.42.

What is the price target of Biodesix Inc (BDSX)?

The analyst target price is $30.00, representing +95.8% upside from the current price of $15.32.

What is the intrinsic value of Biodesix Inc (BDSX)?

Based on our DCF model, intrinsic value is $19.42, a +46.7% margin of safety versus $15.32.

What is Biodesix Inc's revenue?

TTM revenue is $88.50M.

Company info

SectorHEALTHCARE

IndustryDIAGNOSTICS & RESEARCH

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.29x

ROE-383.10%

Beta0.43

50D MA$14.28

200D MA$9.67

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BDSX vs LLY →BDSX vs JNJ →BDSX vs ABBV →Stock screener →